Literature DB >> 14710063

A randomized, controlled trial to compare ketorolac tromethamine versus placebo after cesarean section to reduce pain and narcotic usage.

Jerry L Lowder1, Donald P Shackelford, Don Holbert, Todd M Beste.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether postcesarean section administration of ketorolac tromethamine reduces pain and narcotic usage. STUDY
DESIGN: A double-blinded randomized, placebo-controlled trial of ketorolac tromethamine was performed. Patients were randomly assigned to receive either ketorolac tromethamine or placebo. Patient-controlled analgesia (PCA) was used for pain control. Visual analog scales (VAS) were administered postoperatively to assess pain levels. Morphine equivalents and attempts were recorded.
RESULTS: There were 22 patients in each arm of the study. There was no significant difference between patient demographics, blood loss, and type of anesthesia. Pain scores were significantly different at 2, 3, 4, 6, 12, and 24 hours by analysis of variance (ANOVA) (P=.033). There was a significant decrease in pain medication usage (P=.008) in the study group.
CONCLUSION: Ketorolac tromethamine is efficacious in reducing postoperative pain and narcotics usage after cesarean section.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710063     DOI: 10.1016/j.ajog.2003.08.014

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Effects of preemptive analgesia in laparoscopic cholecystectomy: a double-blind randomized controlled trial.

Authors:  Trichak Sandhu; Sahattaya Paiboonworachat; Wasana Ko-iam
Journal:  Surg Endosc       Date:  2010-06-30       Impact factor: 4.584

Review 2.  Analysis of Multiple Routes of Analgesic Administration in the Immediate Postoperative Period: a 10-Year Experience.

Authors:  Nalini Vadivelu; Alice M Kai; Feng Dai; Susan Dabu-Bondoc
Journal:  Curr Pain Headache Rep       Date:  2019-03-11

3.  Ketorolac Use Shortens Hospital Length of Stay After Bariatric Surgery: a Single-Center 5-Year Experience.

Authors:  Kamyar Hariri; Elizabeth Hechenbleikner; Matthew Dong; Subhash U Kini; Gustavo Fernandez-Ranvier; Daniel M Herron
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 4.  Postoperative pain control.

Authors:  Veerabhadram Garimella; Christina Cellini
Journal:  Clin Colon Rectal Surg       Date:  2013-09

5.  Benefits of a Multimodal Regimen for Postsurgical Pain Management in Colorectal Surgery.

Authors:  David E Beck; David A Margolin; Sheena Farragut Babin; Christine Theriot Russo
Journal:  Ochsner J       Date:  2015

6.  A randomized, clinical trial of ketorolac tromethamine vs ketorolac trometamine plus complex B vitamins for cesarean delivery analgesia.

Authors:  J J Beltrán-Montoya; T Herrerias-Canedo; A Arzola-Paniagua; F Vadillo-Ortega; Omar Felipe Dueñas-Garcia; H Rico-Olvera
Journal:  Saudi J Anaesth       Date:  2012-07

7.  Single-dose intravenous ketorolac for acute postoperative pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17

8.  Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial.

Authors:  Nathan R Blue; Cristina Murray-Krezan; Shana Drake-Lavelle; Daniel Weinberg; Bradley D Holbrook; Vivek R Katukuri; Lawrence Leeman; Ellen L Mozurkewich
Journal:  Am J Obstet Gynecol       Date:  2018-03-02       Impact factor: 10.693

9.  The effects of indomethacin, diclofenac, and acetaminophen suppository on pain and opioids consumption after cesarean section.

Authors:  Godrat Akhavanakbari; Masood Entezariasl; Khatereh Isazadehfar; Fariba Kahnamoyiagdam
Journal:  Perspect Clin Res       Date:  2013-04

10.  Disposition of cimicoxib in plasma and milk of whelping bitches and in their puppies.

Authors:  M Schneider; A Kuchta; F Dron; F Woehrlé
Journal:  BMC Vet Res       Date:  2015-07-31       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.